The effect of intravenous infusion of 10% glycerol on regional cerebral blood flow (using hydrogen bolus and ['33Xe] clearance methods) and metabolism was investigated in 57 patients with recent cerebral infarction. Hemispheric blood flow (HBF) increased, together with increase in regional cerebral blood flow (rCBF) and cerebral blood volume (rCBV), in foci of brain ischemia. Hemispheric oxygen consumption (HMIO2) decreased together with hemispheric respiratory quotient. Systemic blood levels of glucose, lactate, pyruvate, and triglycerides also increased after glycerol while free fatty acids (FFA) and inorganic phosphate (Pi) decreased. Hemispheric glucose consumption was unaltered after glycerol so that hemispheric glucose to oxygen ratio tended to rise. Pyruvate and lactate production by brain was unchanged. Glycerol moved across the blood brain barrier into brain and cerebrospinal fluid (CSF). Release of FFA and Pi from infarcted brain was reversed by glycerol. Total phosphate balance was maintained across brain both before and after glycerol infusion. Triglycerides increased in CSF after glycerol, originating either from cerebral blood or as a result of lipogenesis in cerebral tissue. The EEG recording and neurological status of the patients improved despite decreased brain oxygen consumption. Results of this study suggest that after intravenous infusion of 10% glycerol in patients with recent cerebral infarction, glycerol rapidly enters the CSF and brain compartments and favorably affects the stroke process in two ways: first, by redistribution of cerebral blood flow with increase in rCBF and rCBV in ischemic brain secondary to reduction in focal cerebral edema; and second, glycerol may become an alternative source of energy either by being directly metabolized by the brain, or indirectly, by enhancing lipogenesis, or by both processes. Involvement of glycerol in lipogenesis with esterification to accumulated FFA might lead to improved coupling of oxidative phosphorylation, a hypothesis that fits the finding of improved neuronal function despite further decrease in cerebral hemispheric oxygen consumption.
blood flow (HBF), decreased intracranial pressure, and reduction in hemispheric metabolic index of oxygen consumption (HMIO2), hemispheric carbon dioxide production, and hemispheric respiratory quotient. 5 This reduction in HM102 and HMIC02, despite improved HBF, EEG, and presumed relief of cerebral edema, was considered paradoxical and indicative of a specific metabolic effect of glycerol in infarcted brain. The present report deals with a larger series of patients with acute and subacute cerebral infarction than previously reported. This extended study was attempted not only to confirm earlier results but also to substantiate whether the sources of the apparently beneficial effect of glycerol on ischemic brain function are due to hemodynamic factors, metabolic factors, or a combination of the two.
Since previous studies had shown HBF increase in the infarcted hemisphere was less than would be expected considering the degree of EEG and clinical improvement that eventually resulted,5 8 cerebral hemodynamics were again studied with particular emphasis on possible redistribution of flow and alteration of blood volume in focal ischemic areas. This was evaluated for the first time by means of regional cerebral blood flow (rCBF) and regional cerebral blood volume (rCBV) measurements using 133Xe.
The question as to the direct metabolism of glycerol in infarcted brain has not been directly answered. The previous paradoxical finding that most cases studied showed improvement in neurological deficit and EEG despite decrease in hemispheric metabolic consumption of oxygen has not been fully explained. Recovery of mitochondrial respiratory control with partial or complete reversal of uncoupled oxidative phosphorylation presumed to exist in focal regions of infarcted brain was hypothesized to explain this further decrease in HMI02 after glycerol. In the present study, measurement of cerebral arteriovenous differences and cerebrospinal fluid (CSF) levels of additional metabolic parameters have been performed in the hope of further establishing that glycerol is directly metabolized in ischemic brain tissue, considering it as a possible substrate for cerebral energy metabolism and also as a participant in lipogenesis.
Previous studies of patients with subacute cerebral infarction also had shown a negative cerebral arteriovenous (AV) difference for inorganic phosphate (Pi) which was thought to indicate increased cerebral Pi pool due to breakdown of organic phosphate compounds such as high energy phosphates and phospholipids, with Pi release in cerebral venous blood facilitated by damage to the blood brain barrier.'5 8 The present study incorporates a continuous measurement system of cerebral AV differences for Pi together with CSF Pi levels to con-firm this finding. The method of separate sampling used in earlier studies may not be accurate. Continuous measurements also permitted observations of dynamic changes in Pi exchange across the brain during glycerol infusion.
Total phosphate was also measured across infarcted brain. In the previous studies, the degree of Pi release measured in the acute states after infarction would have been expected to deplete brain Pi pool unless Pi release was balanced by movement of some other organic phosphate compound into brain. Cerebral AV differences for total phosphate were therefore measured in this series to establish if phosphate balance is indeed maintained in infarcted brain.
Finally, alterations in systemic metabolic parameters produced by glycerol were also more closely observed in the present study, and the significance of change in these parameters is discussed in relation to cerebral hemodynamics and metabolism.
Materials
Hemispheric blood flow and metabolism were examined in 57 patients with acute and subacute cerebral ischemia and infarction confirmed by clinical examination, EEG, angiography, brain scan, CSF examinations, and at autopsy some months later in three cases. Age, sex, clinical diagnosis, grade of severity, associated disease, and the interval of time between the ischemic episode and the time of measurement of CBF and metabolism are listed in table 1. Thirty-one males and 26 females were studied, ranging in age from 43 to 83 years with a mean age of 63. Mean duration between onset of cerebral ischemia and the procedure was 11 days. Forty-eight patients had cerebral hemispheric infaretion and nine had brain stem ischemia or infaretion.
The clinical course and severity of the stroke were graded into grades I through IV as follows:
The duration of localized neurological deficit did not exceed 24 hours and recovery was complete. Grade II -Reversible Ischemic Neurological Deficit (27) The neurological deficit, consisting of hemiparesis, monoparesis, or dysphasia, persisted longer than 24 hours, but recovery was virtually complete within three weeks. Grade III -Presumed Cerebral Infarction with Moderate Residual Disability (21) Moderate residual disability persisted after three weeks despite steadily progressive recovery. Grade IV -Presumed Cerebral Infarction with Severe Neurological Deficit (9) A severe neurological deficit persisted after three weeks with little or no evidence of recovery thereafter.
Four patients were given oral or intravenous glycerol for several days, but this was discontinued one or two weeks prior to the measurements of CBF and metabolism. Nevertheless, in these patients, residual effects of glycerol therapy on the metabolic parameters were still measurable, i.e., the blood and CSF glycerol levels were above normal. All measurements were made after nine to 14 hours in the fasting state.
Circulation, Volume 51, April 1975 Procedure for Obtaining Informed Consent Suitable patients were selected for admission to the study by two or more staff neurologists after review of the patients' records. Patients with contraindications such as severe cardiac or renal disease were excluded from the study. Each patient was then seen in consultation by a cardiologist and was not admitted to the study if there were cardiological or medical contraindications to the procedure.
The procedure was explained to the patient or the responsible relative on two separate occasions, first by the neurology staff and then by a specially trained nurse who later witnessed the signing of a standard consent form. The consent form described the procedure, including information on catheter placement, any possible risks involved, and stated that further explanation or clarification would be provided upon request. The patient was allowed to withdraw from the procedure at any time.*
Methods
Each patient was premedicated with meperidine hydrochloride (Demerol) 50 mg i. m. and atropine sulfate 0.4 mg i.m. Local anesthesia was induced at all puncture sites by infiltration with 1% procaine hydrochloride.
A catheter was inserted under fluoroscopic control via the basilic vein into the ipsilateral cerebral transverse sinus for sampling of cerebral venous blood and measurement of intracranial venous pressure.9 A second catheter was placed into the superior vena cava to measure central venous pressure. A third catheter was inserted into the internal carotid artery ipsilateral to the side of the infarction to record arterial blood pressure and to inject a bolus of hydrogen saturated saline and radioisotopes for CBF measurement. A final catheter was inserted into the brachial artery to sample arterial blood. Lumbar puncture was performed and a catheter was placed in the subarachnoid space in a cephalad direction to monitor intracranial pressure and to sample CSF. All pressures were continuously monitored at heart level with Statham pressure transducers.
Arterial and cerebral venous oxygen tension, carbon dioxide tension, and pH were recorded by electrodes mounted in flow-through cuvettes, and oxygen saturation was monitored with reflection oximeters." An infrared absorption CO2 gas analyzer was used to measure arterial and cerebral venous total CO2 content after lysis of red cells with lactic acid.1' Hemispheric blood flow was calculated after injection of a bolus of 8-12 ml hydrogen-saturated saline into the carotid artery. The clearance curves of hydrogen were measured by a hydrogen electrode recording of the transverse sinus blood. 12 Regional cerebral blood flow and rCBV were measured by the gamma camera, applied to the lateral aspect of the head, following the intracarotid injection of 4 mCi Xenon-133 (2 ml) and 2.5 mCi Technetium-99m (2 ml).13 Ten minute clearance curves were stored on magnetic tape and analyzed automatically by a computer programmed for providing printouts of [15] [16] [17] [18] [19] [20] regions of interest throughout the infarcted hemisphere. Regional cerebral blood flow and rCBV values were calculated by stochastic analysis (rCBF1,), while *The method for obtaining informed consent was reviewed and approved by the committee for research involving human beings of Baylor College of Medicine and The Methodist Hospital. These committees were composed of physicians, scientists, and suitably qualified nonmedical persons including a priest.
Circulation, Volume 51, April 1975 flow gray and flow white were calculated by twocompartmental analysis. Regional cerebral blood volume was calculated according to the formula of Fieschi et al.', using the mean transit time of 99mTc activity curves.
Metabolic parameters were analyzed in blood samples drawn simultaneously from carotid artery and cerebral transverse sinus before and after glycerol. Glucose in arterial and cerebral venous blood was analyzed continuously and in separate samples." Lactate and pyruvate were measured by the enzymatic method of Rosenberg and Rush. '6 Pi was measured in all patients by an automated colorimetric method adapted for the Technicon Auto-Analyzer.'7 Continuous measurements of arterial and cerebral venous Pi were also made in 23 patients by analyzing arterial and cerebral venous blood through the Technicon Auto-Analyzer, and the results were expressed as mg/dl of whole blood. Careful adjustment of the equipment reduced the methodological error to 1% within two hours (0.018 mg/dl by replicate sampling).
Serum phospholipid phosphorus was measured by a semiautomated method using the Technicon Auto-Analyzer.'8 Total phosphate was determined colorimetrically.'9 Triglycerides and glycerol were measured using a semiautomated fluorometric method.20 Glycerol was used in the blank as a background for the determination of triglycerides. Estimations of plasma total FFA concentrations were made by a colorimetric method based on the formation of FFA copper complexes." More detailed analysis of the FFA components was carried out by gas-liquid chromatography, using a modification of the Dole technique,"2 plus mass spectrometry. Total FFA levels determined by the two methods were in good agreement.
Glycerol, triglycerides, and Pi were also analyzed in CSF samples taken before and after glycerol infusion.
Results
Cerebral Hemodynamics Before and After Glycerol Values for HBF measured by the hydrogen bolus technique before and after intravenous infusion of 10% glycerol are shown in table 2. Steady-state HBF of the infarcted hemisphere was reduced by about one-third when compared to normal quoted values.2' HBF values increased significantly in all 57 cases studied immediately after glycerol, although the increase was small. HBF was also measured 50 min after infusion was completed in 23 out of 57 cases. Values increased from a mean of 27.8 ± 2.47 in the steadystate to 28.5 ± 2.5 after glycerol. This latter group suffered more severe infarction with greater neurological deficit, therefore, HBF prior to glycerol infusion was reduced to a greater extent in these patients than in the group as a whole. Furthermore, increases in flow after glycerol were understandably less when measured one hour after the glycerol infusion had been discontinued.
Regional cerebral blood flow (rCBF) and rCBV were measured by the 133Xe technique concurrently with the hydrogen bolus method in 31 patients. Steady-state mean hemispheric rCBV values were obtained by the hydrogen bolus technique correlated closely with those obtained by intracarotid injection of II  II  Iv  III  II  II  III   III   III   II   III  II   IV   II  II   III  II  II  Iv  III  III  IIl  II   III  II  II  II  II   III   II   II  II  II  II  II   Iv   III  III  II  Iv   II   III  III  III  Iv  III Abbreviations: R = right; L = left; MCA = middle cerebral artery. 133Xe (r = 0.832), except in eight cases with internal carotid artery occlusion in which the 133Xe curves were heavily contaminated with extracranial circulation. Strong correlation was also observed after glycerol (r = 0.885). Mean hemispheric rCBF increased after glycerol infusion from 29.3 ± 6.4 to 33.3 ± 7.6, confirming the findings of flow increase measured by the hydrogen bolus technique, although the degree of increase is apparently somewhat greater than that measured by the latter technique.
Redistribution of blood flow in infarcted brain was studied according to the procedure recommended by Prosenz et al. 24 A region was designated ischemic or hyperemic if its average regional flow was at least 20% below or above the mean hemispheric flow. All regions showing deviation from mean HBF of less than 20% were designated nonischemic.
The largest increase in blood flow and blood volume after glycerol infusion was measured in ischemic gray matter (table 3) . Similar but smaller increases were measured in ischemic white matter. Flow and volume also increased in nonischemic areas, but both were decreased in the hyperemic zones. The significant differences observed between rCBF and rCBV values in different areas of the ischemic hemisphere before glycerol were often no longer evident after the infusion. EEG Continuous EEG recordings were performed concurrently with rCBF and rCBV measurements in 23 patients. Improvement in focal slow-wave abnormality in the infarcted brain area was seen after the infusion of glycerol in the majority of cases. In 21% of patients, focal slow-wave activity was abolished; 47% of patients showed improvement, but in the remaining 32% no change in EEG activity was observed.
Metabolic Effects of Glycerol
Despite the HBF increase, HMIO2, hemispheric carbon dioxide production, and hemispheric respiratory quotient decreased significantly immediately after the infusion of 10% glycerol (table 2); however the decrease was no longer significant 50 min Circulation, Volume 51, April 1975 later. Hemispheric glucose consumption was unaltered in the total group, but in the diabetic patients studied there was a stronger tendency to increase in hemispheric glucose consumption in keeping with previous reports.8 Systemic blood levels of pyruvate and lactate increased significantly after administration of glycerol but cerebral hemispheric production of pyruvate and lactate was not significantly altered.
After glycerol infusion, systemic levels of blood glycerol, as measured in the carotid artery, became markedly elevated (table 4) . No significant cerebral AV difference for glycerol was detected before or after glycerol infusion (table 4, fig. 1 ), yet CSF glycerol levels became markedly increased (table 5) . Systemic blood triglycerides increased after glycerol infusion at which time a large positive cerebral AV difference for triglycerides, not seen in the steady state, was recorded (table 4, fig. 1 ), together with an increase in CSF levels of triglycerides (table 5). Four patients had Abbreviations: HBF = hemispheric blood flow; HMI02 = hemispheric oxygen consumption; HMICO2 = hemispheric carbon dioxide production; HMIGl = hemispheric glucose consumption; HG:O = glucose to oxygen ratio; HRQ= hemispheric respiratory quotient. Abbreviations: rCBF = regional cerebral blood flowx; rCBV = regional (eTrebral blood voluime; Fg blood flow in gray matter; Vg = voltume blood flow in gray matter; Fw = blood flow in white matter; Vw = volumile blood flow in white matter; NI = nioniischemic area; I = ischemic area: H = hyperemic area1. received oral glycerol one to two weeks prior to the study which accounts for the relatively high mean values of both CSF glycerol and triglycerides recorded in the steady state (table 5) . Total FFA were elevated in systemic blood prior to glycerol but were significantly decreased after infusion. Individual analysis of components in seven patients indicated changes in palmitic and linoleic acid fractions (table 6). Cerebral AV differences for total FFA became positive after infusion suggesting brain uptake ( fig. 1 ).
Systemic blood Pi levels were reduced after the intravenous infusion of glycerol (table 7) while total phosphate and phospholipid phosphorus levels did not change.
Cerebral AV differences for Pi were measured both by separate and continuous sampling. Continuous measurement of cerebral AV differences for Pi was carried out in a total of 23 cases also subdivided into acute and subacute, ischemic and hemorrhagic groups for analysis. In the total group studied, steady-state Pi concentrations in cerebral venous blood were significantly higher than those in arterial blood, which confirmed the movement of Pi into cerebral venous blood from ischemic brain seen on interval sampling measurements. During and up to 60 min after intravenous administration of glycerol, the negative AV difference for Pi was reduced as shown in table 7 and in the acute group in figure 2. Reduction of the Pi release into cerebral venous blood by glycerol was ap- parently more striking in patients with acute infarction than in those with subacute infarction and in those with ischemic compared to hemorrhagic infarction (table 7) . The effect of glycerol in preventing Pi release from infarcted brain was confirmed by Pi measurements of separate blood samples taken after infusion ( fig. 1 ) and supported by a significant decrease in CSF Pi levels after glycerol infusion (table   6) . Cerebral AV differences for total phosphate or phospholipid phosphorus showed neither release nor uptake across the blood brain barrier in the steady state or after glycerol so that the Pi release from infarcted brain observed in the steady state must be balanced by movement of organic phosphate compounds into brain.
Discussion

Steady-State Observations
Values for HBF measured by the hydrogen bolus technique and mean hemispheric regional cerebral blood flow (rCBF) values measured by clearance of Xe were found to be closely correlated. Due to some unavoidable extracranial contamination, steady-state values for mean hemispheric rCBF obtained by exter- The effect of glycerol infusion on cerebral arteriovenous differences for metabolites. This shows that intravenous infusion of 10%/ glycerol reverses the initial release offreefatty acids and inorganic phosphate (Pi) from infarcted brain and that total phosphate balance across the brain is maintained at all times despite the observance of Pi release in the steady state. Absence of a significant cerebral AI' differetnce for glycerol after infusion refiects rapid equilibration of glycerol movement into and out of intracranial compartments. A positive cerebral AV' difference for triglycerides after glycerol suiggests that uwhen systemic arterial levels increase, triglycerides leak into brain presumably becatuse of blood brain barrier damage. statistically significant difference from zero; statistically significant difference compared to steady state valuies; N = number of measturements. nal counting from the head after carotid injection of 133Xe were slightly lower than those for HBF calculated by hydrogen clearance measured in blood from the transverse sinus within which virtually no blood of extracerebral origin is present. HBF, HMIO2, and hemispheric carbon dioxide production of the infarcted cerebral hemisphere showed abnormally low values compared to those normally quoted.23 This finding was in keeping with many earlier studies of stroke patients performed in this laboratory. 5 8 
Cerebral Hemodynamic Effects of Glycerol
Increased HBF, mean hemispheric rCBF and rCBV in patients after infusion of 10% glycerol may be attributed to its well known hyperosmolar effect in decreasing intracranial pressure and cerebral edema.' -Increased rCBF and rCBV in foci of ischemia involving both gray and white matter can best be explained on the basis of decrease in regional brain tissue edema. As compression of the microcirculation is relieved effective redistribution of blood flow to previously ischemic areas occurs. After glycerol infusion, areas of hyperemia correspondingly became fewer as areas of ischemia were decreased. Nonischemic brain areas showed only mild increases in blood flow and blood volume after glycerol, probably secondary to over-all decrease in intracranial pressure. By the same mechanism, rCBF might reasonably be expected to increase to the same order in the nonischemic hemisphere. The apparent disparity and greater increase in blood flow to the infarcted hemisphere after glycerol, Circulation, Volume 51, April 1975 Effects of intravenous infusion of 10% glycerol on continuous records of inorganic phosphate (P) in arterial and cerebral venous blood. This shows mean values obtained by continuous measurement of inorganic phosphate (Pi) levels in arterial (c) and cerebral venous (o) whole blood before, during, and after intravenous infusion of 10% glycerol. Note the early fall in arterial Pi levels during infusion and the abolition of the initial negative AV difference for Pi toward the end of infusion. P < 0.05 significant changes of Pi of arterial and cerebral venous blood compared to steady-state values; N = number of measurements. Solid bar and broken bar represent SD of arterial and cerebral venous blood, respectively. detected by the isotope technique (mean hemispheric rCBF) compared to the hydrogen bolus method (HBF), is due in part to the different number of cases studied in the two groups but also may be attributed to the relatively larger increases of flow in ischemic areas that can be detected by rCBF measurements since mean hemispheric rCBF is a calculated value for the total regions. Furthermore, although HBF increases are small, redistribution with reperfusion of ischemic areas is highly effective. Increased blood flow and blood volume in ischemic regions also coincided with focal EEG improvement.
Systemic Metabolic Effects of Glycerol
After intravenous infusion of glycerol, systemic blood levels of glucose, lactate, pyruvate, and triglycerides increased while levels of FFA and Pi decreased. Total phosphate was unchanged. Concentrations of glycerol attained in the systemic circulation were also maintained.
Glycerol is an important endogenous precursor of glucose in the body where it is normally released from adipose tissue as a result of lipolysis.26 Gluconeogenesis in the liver with formation of the intermediate compound glycerol phosphate is the most likely ex-planation for increase in blood glucose and decreased blood Pi after infusion.27 The effect of glycerol on systemic blood glucose levels must be borne in mind when treating patients with diabetes mellitus and stroke.
Significant elevation of systemic blood pyruvate and lactate in patients given glycerol may be accounted for in part by elevation of blood glucose, which in normal individuals results in increased pyruvate and lactate turnover in skeletal muscle. 28 Part of the decrease in circulating phosphate pool could also be explained on this possible promotive effect on skeletal muscle metabolism.
Esterification of glycerol with FFA to form triglycerides occurring in liver is believed to be largely responsible for the systemic elevation of triglycerides and reduction of FFA seen in the present study. However, systemic FFA reduction may also be caused by increased insulin secretion that occurs secondary to increased systemic glucose levels.29 Whereas increased blood triglycerides might theoretically increase blood viscosity, thereby predisposing collateral flow to ischemic brain areas,30 such a factor appears to be of minimal importance in view of the overriding beneficial hemodynamic changes produced by relief of regional brain edema.
Cerebral Metabolic Effects of Glycerol
Results of the present series of cases confirmed earlier studies in smaller series that intravenous infusion of 10% glycerol given to patients with acute cerebral infarction produces significant increases of HBF associated with decrease in HMIO2, hemispheric carbon dioxide production, and hemispheric respiratory quotient despite EEG and clinical improvement. Decreases in HMIO2 and hemispheric carbon dioxide production after glycerol are small compared to the extent of reduction in steady-state values from those normally quoted.23 However, increase in these parameters, even though of low order, has previously been reported in spontaneous recovery from cerebral infarction after several weeks.25 31 Attempts to explain this apparently paradoxical situation are offered below. It should be pointed out that patients who exhibit complete recovery of neurological function from previously sustained ischemic deficit still show marked reduction of HMI02 and hemispheric carbon dioxide production when compared to normal populations.
Hemispheric glucose consumption was not altered after glycerol but glucose to oxygen ratio tended to increase. Unaltered hemispheric glucose consumption after glycerol, in the face of rise in arterial glucose levels, makes it unlikely that the beneficial cerebral metabolic effects of glycerol reflect merely a transition Circulation, Volume 51, April 1975 from a fasting to a fed state. Infusion of glucose alone to fasting stroke patients has previously been shown in this laboratory to promote increased cerebral glucose consumption. 5 Lactate and pyruvate release from brain were not significantly altered, suggesting absence of shift to increased anaerobic metabolism.
Results of continuous recording of cerebral AV differences again showed release of Pi into cerebral venous blood and CSF. Inorganic phosphate release into cerebral venous blood observed in previous studies5 8 was therefore confirmed, and cannot be accounted for by random fluctuations in steady-state Pi levels since both continuous observations made in the steady state and during glycerol infusion, in addition to intermittent sampling, exclude this possibility. Since no significant cerebral AV difference for total phosphate was observed, it may be concluded that over-all cerebral phosphate balance is maintained by movement of inorganic phosphate compounds into the brain to replace the Pi loss. No significant brain uptake of phospholipid phosphorus was observed in the steady state. It seems that other organic phosphate compounds, e.g., glycerol phosphate, must move into brain to maintain cerebral Pi balance after infarction. Further study is required to establish these events and the exact nature of the biochemical exchange.
Explanation of the cause for measurable Pi release from infarcted brain can only be speculative. Increased cerebral Pi pool in the presence of a damaged blood brain barrier appears to be the best since it has been consistently shown in animals that cerebral ischemia and anoxia impair cerebral mitochondrial oxidative phosphorylation with resultant depletion of cellular adenosine triphosphate and phosphocreatine with an accumulation of adenosine diphosphate and Pi.32. 33 The presence of both blood brain barrier damage and ischemic increase in cerebral Pi pool is further supported in our study by an apparently greater effect of glycerol in preventing cerebral Pi release in the more acute ischemic cases. Furthermore, other studies have suggested that cerebral ischemia may result in too large an accumulation of Pi to be solely accounted for by concomitant reduction in the high energy phosphate pool,34 35 SO it seems reasonable to postulate that an important source for increased Pi pool in infarcted brain might be breakdown of other phosphate-containing compounds such as phospholipids. Significant FFA release from infarcted brain was again observed and is interpreted as indicative of increased FFA accumulation in ischemic brain tissue, an event that has been described in previous studies. 35 Mechanisms that bring about tissue FFA accumulation cannot be identified in this study. One explanation might be the breakdown of membrane com-ponents such as phospholipids and triglycerides in ischemic brain areas. This hypothesis is indirectly supported not only by findings suggestive of increased cerebral Pi pool previously commented on but also by the steady-state findings of increased CSF triglyceride levels in the absence of significant cerebral AV difference for triglycerides to suggest origin from cerebral blood.
Measurement of cerebral AV differences and CSF levels for parameters studied can, of course, provide only indirect evidence of pathways for glycerol metabolism in the human brain. Glycerol increases in CSF after infusion confirms its entry into central nervous system compartments. The fact that a statistically significant positive cerebral AV difference for glycerol was not measured by the sampling method suggests rapid equilibration of glycerol into and out of central nervous system compartments.
Cerebral metabolic effects of glycerol, if any, also cannot be explained by increased systemic glucose production since cerebral glucose consumption is unaltered. Although controversy exists on the issue of glycerol metabolism in brain tissue, several studies strongly suggest that glycerol can be metabolized by brain36-38 although the question remains as to the exact pathway. Authorities appear agreed that lipogenesis may be one result of glycerol metabolism,39 but its role in supporting energy metabolism is uncertain. Entry of glycerol into metabolic pathways depends on glycerol kinase, an enzyme that is present in only small amounts in brain tissue. 40 41 Nevertheless, tracer studies with`4C glycerol provide evidence that glycerol is oxidized in brain tissue,40 as well as demonstrate`4C glycerol uptake into phospholipids and triglycerides, probably through the intermediate formation of phosphatidic acid. 36 39, 40 We believe that the findings of the present study support the hypothesis that glycerol is directly metabolized in brain tissue of patients studied. Reversal of Pi release from infarcted brain after glycerol (evidenced by reduction of the negative AV differences for Pi and fall in CSF Pi levels) is in keeping with the increased utilization of cerebral Pi pool, possibly because of high energy phosphate formation and improved energy metabolism. Similar reversal of FFA release after glycerol could result from improved cerebral lipogenesis leading either to increased phospholipid formation or perhaps esterification of FFA with glycerol to form triglycerides. Increased phospholipid formation would also utilize free Pi pool.
Although triglyceride formation probably only occurs to a minimal extent in brain tissue, the finding of increased CSF triglycerides after glycerol suggests that such a metabolic pathway may indeed exist. This assumption is further supported by the fact that the patients who had been given oral glycerol one or two weeks prior to the blood flow measurement showed higher steady-state CSF concentration of triglycerides despite CSF glycerol levels being less elevated. However, a positive cerebral AV difference for triglycerides after glycerol infusion also suggests that systemic blood triglycerides may pass into CSF across a damaged blood brain barrier. More detailed analysis and comparison of serum and CSF triglyceride fractions might establish the source of the elevation. Is brain tissue metabolism of infused glycerol the explanation for the paradoxical decrease in HMIO2 and hemispheric carbon dioxide production despite improved EEG and neurological function in the patients studied? The possibility that reduction in HMIO2 was an artifact of reestablishment of perfusion through nonmetabolizing areas of infarcted brain leading to reduced withdrawal of oxygen from tissue can be rejected by the findings of constant cerebral glucose consumption and improved EEG. By the same process, the Crabtree effect (whereby inhibition of endogenous cell respiration occurs as a result of increased exogenous glucose utilization)42 can also be rejected. Enhancement of anaerobic glucose metabolism by glycerol could further impair neuronal metabolism by the deleterious effect of increasing tissue lactic acidosis. However, no shift to anaerobic metabolism was evident in the present study as judged by no change in the pyruvate and lactate production by brain.
Decreased HMIO2 despite increased rCBF and improved EEG after glycerol seems to us best explained by improved coupling of oxidative phosphorylation to cell respiration, assuming that such a condition exists regionally in focal areas of infarcted brain. The fact that HMIO2 was reduced does not exclude the possibility of regional uncoupling of oxidative phosphorylation existing in ischemic brain areas. However, direct support for this concept could not be obtained due to the unavailability of methods for measurement of regional cerebral oxygen consumption in our hospital.
Decreased HMIO2 after glycerol also coincides with decreased release of FFA from infarcted brain. Cellular FFA accumulation has been shown to impair mitochondrial respiratory control by uncoupling oxidative phosphorylation.43 4 This event appears coincidental with brain tissue and mitochondrial swelling.45 46 Further study is indicated to explore the effect of increased circulating FFA on ischemic brain metabolism in the light of elevated plasma FFA also measured in the present study. Esterification of FFA with glycerol, as suggested in earlier paragraphs, could remove any deleterious effect that cellular FFA accumulation might exert on mitochondrial function Circulation, Volume 51, April 1975 and perhaps result in improved oxidative phosphorylation with recovery of cellular respiratory control. This should in turn lead to improved energy metabolism (supported by Pi uptake from cerebral pool) and neuronal function, the latter being evident in the present study by improvement of EEG and clinical functioning.
In conclusion, results of this study suggest that after intravenous infusion of 10% glycerol in patients with recent cerebral infarction, glycerol rapidly enters the CSF and brain compartments to favorably influence the stroke process; first, redistribution of cerebral blood flow with reperfusion of ischemic brain areas brought about by reduction in focal cerebral edema, and second, direct metabolization of glycerol by brain, either as substrate for energy metabolism, or is involved in lipogenesis, or both. Involvement of glycerol in lipogenesis with esterification to accumulated FFA might lead to improved coupling of oxidative phosphorylation with cell respiration, a hypothesis that we feel best explains the findings supportive of improved neuronal function despite further decrease in cerebral oxygen consumption of ischemic brain.
